导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.99% | 608/1050 |
| 近一周 | -2.18% | 482/1104 |
| 近一月 | -4.15% | 520/1102 |
| 近一季 | -8.20% | 589/1092 |
| 近半年 | -2.86% | 508/1070 |
| 近一年 | 1.20% | 558/1018 |
| 近两年 | 41.74% | 564/926 |
| 近三年 | 25.21% | 430/834 |
| 成立以来 | 102.21% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.87% 759/1070 |
13.47% 484/1101 |
- - |
- - |
| 2025 | 18.43% 687/1065 |
-0.56% 832/1014 |
1.29% 569/1038 |
16.28% 718/1050 |
1.12% 386/1065 |
| 2024 | 15.58% 158/1011 |
2.81% 172/960 |
-1.21% 389/983 |
16.09% 171/991 |
-1.97% 449/1011 |
| 2023 | -5.12% 203/952 |
5.01% 328/880 |
-2.23% 318/895 |
-1.42% 132/915 |
-6.26% 616/952 |
| 2022 | -17.89% 251/867 |
-13.50% 199/773 |
6.02% 457/806 |
-12.81% 449/845 |
2.69% 289/867 |
| 2021 | 6.48% 281/740 |
-0.46% 169/580 |
5.10% 466/659 |
-3.05% 292/704 |
4.99% 224/740 |
| 2020 | 45.65% 265/554 |
-7.52% 346/419 |
16.60% 328/466 |
17.85% 82/517 |
14.62% 212/554 |
| 2019 | 40.43% 217/410 |
23.28% 825/1146 |
2.13% 160/1228 |
2.12% 275/390 |
9.22% 184/410 |
| 2018 | -19.20% 62/349 |
- - |
-6.56% 236/990 |
-0.30% 181/1000 |
-11.62% 500/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 中信保诚量化阿尔法股票A VS. 东吴新产业精选股票A(580008) |